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Summary
The aim of the current study was to analyze the relationships between plasma hormones, body 
weight parameters and stressful life events in anorexia nervosa (AN).
72 females in the active phase of AN were evaluated. 52 healthy women constituted the con-
trol group. RIA kits were used to measure plasma hormone levels. 
The concentrations of leptin, insulin, IGF-1, triiodothyronine, LH, FSH, estradiol, and testosterone 
were significantly lower and those of cortisol and growth hormone significantly higher in the AN 
than the control group. No hormonal differences between restrictive and binge-purging AN sub-
types were found. Leptin, IGF-1, gonadotropins, and sex steroids correlated significantly negatively 
and growth hormone positively with total reduction of body weight or the degree of undernutrition. 
Associations were also found between lower insulin concentration and family violence, lower corti-
sol and psychiatric diseases in the family, higher testosterone and patient’s alcohol or drug abuse. 
The changed activity of the somatotropin-somatomedin, gonadal, and corticotrophin axes 
corresponds to the clinical stage of AN. Plasma IGF-1 seems to be the most sensitive and use-
ful independent hormonal marker of cachexia.
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IntroductIon
It is still uncertain whether the psychiatric and/or endo-
crinal disturbances in anorexia nervosa (AN) are the re-
sults of a primary hypothalamic disorder or are indicative 
of longstanding malnutrition [5,51]. Body weight appears 
to be a crucial determinant of such dysregulation [5,11]. 
Puberty may itself be a risk factor of AN onset, which is 
why this disease most commonly develops during adole-
scence or young adulthood [28]. The European Symptom 
Checklist For Mental Disorders (ICD–10) describes distur-
bances of multiple hormonal axes in anorexia [24]. Ame-
norrhea is one of the main AN diagnostic criteria, which 
also include disturbed body image, fear of obesity, and 
aiming at minimal weight even when significantly un-
derweight [1,24]. The American Psychiatric Association 
(DSM-IV) distinguishes the restricting subtype where low 
weight is maintained largely by caloric restriction and 
the bingeing/purging subtype with both binge eating 
and purging by vomiting, use of laxatives, diuretics, ene-
mas and exercise [1]. Hypoleptinemia is believed to be 
the major signal underlying both somatic and behavioral 
adaptation to starvation [37]. Leptin, an adipose tissue-
-derived adipocytokine, contributes to mechanisms re-
sponsible for body weight and energy balance regulation 
[19,54]. Receptors for leptin have been found in the brain 
and peripheral glands and it acts as a negative-feedback 
signal [15]. A certain threshold of leptin is necessary to 
activate the hypothalamic-pituitary-gonadal and thyroid 
axes, whereas the hypothalamic-pituitary-adrenal and 
growth hormone (GH)-insulin-like growth factor 1 (IGF-
1) axes may be largely independent of circulating leptin 
levels in humans [6,35,38]. On the other hand, hypolep-
tinemia may be subsequent to the decreased nutritional 
state and predicts secretion of estradiol, thyroid hormo-
nes, cortisol, and GH [35]. The role of leptin in abnormal 
eating behavior is unclear [38].
The recent literature focuses on the possible role of the 
hormones, severe life events and chronic stress as factors 
capable of influencing the onset and the course of eating 
disorders [30]. These psychoendocrine associations might 
be important for multidisciplinary and complementary 
AN treatment. The aim of the current study was to explore 
the relationships between selected clinical features, envi-
ronmental (familiar) stressors and plasma concentrations 
of a broad spectrum of hormones involved in psychoen-
docrine reaction to prolonged starvation in patients with 
an active stage of anorexia nervosa.
MaterIals and Methods
Participants
The study group consisted of 72 females aged 20.7 ± 3.5 
years, admitted to the inpatient and outpatient services 
of the Psychiatry and Endocrinology Departments of Po-
meranian Medical University in Szczecin from 1997 to 
2007. All the patients met the criteria for anorexia ne-
rvosa of the Diagnostic and Statistical Manual for Mental 
Disorders, 4th ed., rev. (DSM-IV) [1], and the International 
Classification of Mental Disorders and Behavioral Distur-
bances, 10th ed., rev. (ICD-10) [24]. Forty-nine patients 
had the restrictive type of anorexia (AN-R) and 23 were 
bulimic (AN-B). Before blood sampling, all the partici-
pants were evaluated by a semi-structured clinical in-
terview (SCID) for current or prior psychiatric illnesses 
suffered either by them or their first-degree relatives 
and their environmental situation (negative life events 
in patient’s life up to the moment of gathering data), 
alcohol or other substance abuse, and self-destructive 
behavior. The control group was composed of 52 heal-
thy women who were mostly a representative group of 
medical students with an average age of 27.1 ± 6.3 years, 
with no history of an eating disorder or any substance 
abuse. None of the participants had received medication 
or hormonal therapy for a period of at least four weeks 
before the experiment. They were free of any somatic 
diseases such as primary endocrine, autoimmune, and 
gastrological disorders. Neurological processes that mi-
ght cause central nervous system deficits were also exc-
luded as well as pregnancy. All the participants received 
verbal and written information from the investigators 
about the purpose and design of the study. Informed 
consent to participate in this study was obtained from 
each participant and from the parents of the minors 
taking part in it. The experimental protocols were re-
viewed and approved by the Ethics Committee of the 
Pomeranian Medical University of Szczecin.
Hormone assays
Blood samples were collected in the early morning after 
an overnight fast and rest. In menstruating women a sam-
ple for hormonal measurements was collected in the fol-
liculate phase (6-9th day of the cycle). Plasma was stored 
at -80ºC until assayed. Specific radioimmunoassay (RIA) 
kits were used to measure plasma levels of leptin (LEP) 
(Linco Research, Inc., St. Louis, MO, USA), cortisol (C) 
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(Orion Diagnostica, Espoo, Finland), insulin-like growth 
factor 1 (IGF-1) (BioSource Europe S.A., Belgium), triio-
dothyronine and thyroxine (fT3, fT4) (ZenTech, ANGLEUR 
Belgium), estradiol (E2) (BioSource Europe S.A., Nivelles, 
Belgium), and testosterone (T) (Orion Diagnostica, Espoo, 
Finland). Plasma insulin (IRI), thyroid-stimulating hor-
mone (TSH), follicle-stimulating hormone (FSH), and lu-
teotropic hormone (LH) were measured by immunoradio-
metric assay (IRMA) kits (BioSource Europe S.A., Nivelles, 
Belgium) and human growth hormone (GH) by immu-
noradiometric assay (GH-IRMA) kits (BioSource Europe 
S.A., Nivelles, Belgium). The sensitivities (the lower lim-
its of detection) and intra- and interassay coefficients of 
variation were: 0.5 ng/mL, 3.4-8.3% and 3.0-6.2% for LEP; 
5 nmol/L, 2.6-5.4% and 6.5-7.3% for C; 0.4 μg/L, 3.9-9.5% 
and 5-8% for IGF-1; 1.7 pmol/L, 3.6-4.2% and 3.4-4.8% for 
fT4; 17.6 pmol/L, 5.3-5.8% and 6.8-9.5% for E2; 0.1 nmol/L, 
3.8-7.5% and 4.8-7.0% for T; 1 mIU/L, 1.6-2.2% and 6.1-6.5% 
for IRI; 0.025 mIU/L, 0.6-6.0% and 2.1-4.1% for TSH; 0.1 
IU/L, 1.5-2.7% and 2.0-5.3% for FSH; 0.07 IU/L, 1.0-5.0% 
and 3.3-5.7% for LH; 0.026 mIU/L for GH, respectively.
Nutritional status
Both the total time of illness (TTI, months) and total re-
duction of body weight (TRBW, kg) were determined. 
Some indices of body weight were also calculated, i.e. 
the body mass index (BMI) as the ratio of body weight [kg] 
to [height]2 and %IBW (percentage of ideal body weight) 
as the ratio of actual to ideal body weight (IBW) x 100%, 
where IBW (kg) = height (cm) - 100 - {[(height (cm) – 
150)]/2} according to Lorentz’s formula [31].
Statistical analysis
The normality of distribution of quantitative variables 
was checked with the Shapiro-Wilk test. The statistical 
evaluation of differences between the groups was per-
formed by means of Student t test for normally distribut-
ed variables or nonparametric Mann-Whitney test when 
the distributions were significantly different from nor-
mal. Associations between quantitative variables were 
characterized by Spearman’s rank correlation coefficient. 
The general linear model (GLM) was used for multivari-
ate analysis. Statistica 7.1 software was used for statistical 
calculations. The results are presented as the mean ± SD 
(standard deviation) for normally distributed variables 
and as median (interquartile range) for non-normally 
distributed ones. The level of statistical significance was 
set at p<0.05 and it was not corrected for multiple testing.
results
There was no significant association between the degree 
of undernutrition (TRBW, %IBW) and the type of anorexia, 
but BMI was lower in the restrictive type (Table 1).
The hormone concentrations in the AN-R and AN-B sub-
groups showed no significant differences (Table 2). There-
fore we combined these subgroups and further analyses 
refer to the whole anorectic group. The anorectic and 
control groups were significantly different with regard 
to age, body weight (b.w.), and BMI (Table 3). The con-
centrations of LEP, IRI, IGF-1, fT3, LH, FSH, E2, and T were 
significantly lower and those of C and GH significantly 
higher in the AN group than in the controls (Table 3). 
The associations of social factors and stressful life cir-
cumstances with clinical features and hormone concen-
trations in the patients with anorexia were explored and 
those with statistical significance are presented in Table 
4. The patients with parental alcoholism were signifi-
cantly older and had higher E2 and lower C values, while 
those who abused alcohol themselves had higher T con-
centrations. Drug abuse was associated with younger age 
and higher values of body weight, BMI, and T concentra-
tion. Patients with a history of parental separation or di-
vorce had higher BMI. Lower concentrations of IRI were 
observed in patients with domestic violence, while the 
subgroup with psychological abuse had lower FSH. Pa-
tient’s competition with the mother was associated with 
a longer time of illness, while such behavior towards sib-
Table 1. Clinical parameters of the anorexia (AN) group with division into restrictive (AN-R) and bulimic (AN-B) subtypes.
Group  AN-R (N=49) AN-B (N=23)
p 
Parameter Mean ± SD or median (IQR)
Age [years] 20 (3) 20 (6) 0.93
TTI [months] 24 (36) 36 (60) 0.44
B.w. [kg] 40.3 ± 6.3 42.6 ± 5.2 0.12
TRBW [kg] 18 (9) 17.8 (9) 0.76
BMI [kg/m2] 14.8 ± 1.7 15.7 ± 1.4 0.037
%IBW [%] 65.0 (9.2) 67.0 (9.8) 0.19
Mean ± SD and p-value of Student t test are shown for normally distributed variables while median (interquartile range – IQR) and p-value of Mann-Whitney test 
are presented for variables with distributions different from normal; TTI – total time of illness, B.w. – body weight, TRBW – total reduction of body weight, BMI – 
body mass index, %IBW – percentage of ideal body weight165
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Table 3. Characteristics of the anorexia nervosa (AN) and control (C) groups
Parameter
AN C
p 
N Mean ± SD or median (IQR) N Mean ± SD or median (IQR)
Age [years] 72 20 (5) 52 25 (2) <0.00001
B.w. [kg] 72 41.0 ± 6.0 52 57.5 ± 6.4 <0.00001
BMI [kg/m2] 72 15.1 ± 1.7 52 20.7 ± 1.8  <0.00001
LEP [ng/mL] 63 1.90 (1.80) 52 6.31 (4.78) <0.00001
C [nmol/L] 62 627.1 ± 152.4 52 519.4 ± 159.4 0.00037
IRI [pmol/L] 61 29.42 (15.79) 52 41.98 (21.53) 0.00001
IGF-1 [μg/L] 71 206.4 ± 83.9 52 286.8 ± 65.0 <0.00001
GH [pmol/L] 70 55.69 (116.12) 48 7.89 (54.14) 0.00006
TSH [mIU/L] 61 1.28 (1.29) 52 1.73 (1.45) 0.053
fT3 [pmol/L] 61 4.38 (1.23) 52 5.37 (1.10) <0.00001
fT4 [pmol/L] 61 15.06 (8.24) 52 13.71 (4.63) 0.10
LH [IU/L] 70 1.34 (2.88) 49 5.03 (2.54) <0.00001
FSH [IU/L] 70 3.60 (5.03) 49 5.96 (2.11) <0.00001
E2 [pmol/L] 70 68.05 (81.63) 50 177.45 (131.30) <0.00001
T [nmol/L] 57 1.51 ± 0.74 50 1.86 ± 0.82 0.020
Mean ± SD and p-value of Student t test are shown for normally distributed variables while median (interquartile range – IQR) and p-value of Mann-Whitney test are presented 
for variables with distributions different from normal; B.w. – body weight, BMI – body mass index, LEP – leptin, C – cortisol, IRI – insulin, IGF-1 – insulin-like growth factor 
1, GH – growth hormone, TSH – thyroid-stimulating hormone, fT3 – triiodothyronine, fT4 – thyroxine, LH – luteotropic hormone, FSH – follicle-stimulating hormone, E2 – 
estradiol, T – testosterone
Table 2. Hormonal characteristics of the anorexia nervosa patients stratified into restrictive (AN-R) and bulimic (AN-B) subtypes
Hormone in plasma
AN-R AN-B
p 
N Mean ± SD or median (IQR) N Mean ± SD or median (IQR)
LEP [ng/mL] 44 1.81 (1.90) 19 1.90 (1.56) 0.38
C [nmol/L] 43 623.0 ± 164.6 19 636.5 ± 124.0 0.75
IRI [pmol/L] 42 28.34 (15.79) 19 31.57 (25.12) 0.35
IGF-1 [μg/L] 48 203.7± 76.2  23 212.0 ± 99.8 0.70
GH [pmol/L] 47 62.17 (130.44) 23 30.23 (79.19) 0.22
TSH [mIU/L] 42 1.49 (1.33) 19 1.12 (1.16) 0.24
fT3 [pmol/L] 42 4.34 (1.25) 19 4.45 (1.70) 0.53
fT4 [pmol/L] 42 15.36 (8.88) 19 13.0 (6.57) 0.06
LH [IU/L] 47 1.30 (2.72) 23 1.53 (4.40) 0.33
FSH [IU/L] 47 3.74 (4.60) 23 3.50 (6.09) 0.97
E2 [pmol/L] 47 68.4 (78.69) 23 67.70 (112.30) 0.71
T [nmol/L] 39 1.59 ± 0.72 18 1.32 ± 0.76 0.20
Mean ± SD and p-value of Student t test are shown for normally distributed variables while median (interquartile range – IQR) and p-value of Mann-Whitney test are presented 
for variables with distributions different from normal; LEP – leptin, C – cortisol, IRI – insulin, IGF-1 – insulin-like growth factor 1, GH – growth hormone, TSH – thyroid-
stimulating hormone, fT3 – triiodothyronine, fT4 – thyroxine, LH – luteotropic hormone, FSH – follicle-stimulating hormone, E2 – estradiol, T – testosterone166
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lings correlated with significantly lower LH, FSH, and E2 
concentrations. In patients with a history of psychiatric 
disease in the family, the concentration of cortisol was 
lower than in those free of this stressor.
The correlations between clinical features and nutri-
tional status parameters on the one hand and hormone 
concentrations on the other in the patients and controls 
are presented in Table 5. In the AN group the strongest 
associations concerned IGF-1, which correlated positi-
vely with body weight, %IBW, and BMI (Figure 1) and 
negatively with TRBW. Similar but much weaker asso-
ciations were observed for leptin, LH, FSH, E2, and T. fT4 
correlated positively only with TTI. In contrast to the 
other hormones, GH had a negative correlation with 
%IBW and positive with TRBW. The correlations of IRI 
and TSH and fT3 with body weight parameters were not 
statistically significant. 
In the controls, negative correlations between fT3 and 
body weight and BMI were found, while age correlated 
positively with E2 and negatively with IGF-1 and fT3 (Ta-
ble 5). The other hormones did not significantly correlate 
with body weight parameters in this group.
Correlation between plasma hormone concentrations in 
the AN patients are presented in Table 6. 
Multivariate analysis adjusted for patient age, total time 
of illness, and type of anorexia (restrictive or binge-pur-
ging) revealed that high IGF-1 concentration was a strong 
independent predictor of higher BMI, %IBW, and lower 
TRBW (Table 7).
dIscussIon
Multiple endocrine and metabolic changes are involved in 
the adaptation to survive prolonged starvation in the course 
of anorexia nervosa. To define these mechanisms it is neces-
sary to sum the numerous pathways, as even minor weight 
changes in AN are associated with significant responses in 
basal and dynamic hormonal secretion [11,51]. As regards 
age and duration of illness in anorectic subgroups, no sta-
tistically significant differences were confirmed in our data, 
similarly to other authors [12], although the patients with 
bulimia had a slightly higher (by 0.9 kg/m2) BMI value. This 
difference could be explained by different principles and 
rituals pattern in AN-R and AN-B behavior according to an-
orexia diagnostic criteria. Patients with AN-B who have sig-
Table 4. Clinical features and plasma hormone concentrations according to environmental stress events in AN patients 
Stress event Analyzed parameters
Patients without stress event
Patients with  
stress event
p 
N
Mean ± SD or 
median (IQR)
N
Mean ± SD or 
median (IQR)
Parental alcoholism
Age [years] 35 19 (3) 37 21 (5) 0.046
C [nmol/L] 32 668 ± 132 30 583 ± 163 0.027
E2 [pmol/L] 34 50.7 (50.3) 36 93.4 (73.3) 0.011
Alcohol abuse  
by patient
T [nmol/L] 51 1.44 ± 0.74 6 2.08 ± 0.41 0.045
Drug abuse  
by patient
Age [years] 66 21 (4) 6 18 (2) 0.017
B.w. [kg] 66 40.5 ± 6.0 6 46.5 ± 2.3 0.00028
BMI [kg/m2] 66 14.9 ± 1.7 6 16.4 ± 0.6 0.00019
T [nmol/L] 52 1.43 ± 0.73 5 2.33 ± 0.15 <0.00001
Domestic violence IRI [pmol/L] 31 32 (29) 30 28 (22) 0.004
Psychological abuse FSH [IU/L] 37 3.9 (3.9) 33 2.8 (4.3) 0.045
Parental separation/divorce BMI [kg/m2] 44 14.7±1.8 27 15.6±1.4 0.026
Competition with mother TTI [months] 57 24 (36) 15 48 (84) 0.038
Competition with siblings
LH [IU/L] 39 2.4 (3.7) 31 1.0 (1.1) 0.013
FSH [IU/L] 39 4.8 (5.2) 31 3.0 (3.6) 0.017
E2 [pmol/L] 39 79.5 (9.1) 31 48.9 (73.4) 0.041
Psychiatric diseases
in the family
C [nmol/L] 46 661±130 16 530±175 0.0024
p – statistical significance of difference between patients with and without indicated environmental stress event. Only associations with p<0.05 are shown. Mean 
± SD and p-value of Student t test are shown for normally distributed variables while median (interquartile range – IQR) and p-value of Mann-Whitney test are pre-
sented for variables with distributions different from normal; C – cortisol, E2 – estradiol, T – testosterone, B.w. – body weight, BMI – body mass index, IRI – insulin, 
FSH – follicle-stimulating hormone, TTI – total time of illness, LH – luteotropic hormone167
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nificantly higher BMI in comparison to AN-R are more prone 
to develop bulimia nervosa later [40].
Our observations show that AN-R and AN-B patients have 
similar hormonal profiles and these data may suggest 
that from the metabolic point of view they suffer from 
the same disease. We confirmed total leptin secretion be-
ing significantly lower, both in the restrictive and binge 
eating/purging AN subtypes, than in the normal-weight 
women [8,36,38]. A negative correlation between leptin 
and TRBW and a positive correlation between leptin and 
BMI were found in the AN patients in our study. Some au-
thors observed no significant correlations between leptin, 
BMI, and body weight values in AN [42], while others as-
sumed that the correlation between leptin and BMI was 
preserved independently of any specific pathology [13]. 
Serum leptin concentration corresponds to the true sta-
tus of adipose stores and is supposed to be responsible 
for changes in the neuroendocrine system [8,39]. Leptin 
seems to be a link between the central neuropeptides and 
the hypothalamus–pituitary–peripheral hormones [48]. 
The central anorectic role of leptin is believed to inhibit 
the anabolic (orexigenic) pathway connected with such 
agents as AgRP (Agouti-related protein), NPY (neuropep-
tide Y), β-EP (β-endorphin), MCH (melanin-concentrating 
hormone), galanin, hypocretins (OXA, OXB), glutamate 
and NMDA [48]. On the other hand, leptin seems to stim-
ulate a catabolic (anorexigenic) pathway of the central 
nervous system connected with CRH (corticotrophin-re-
leasing hormone), TRH (thyrotropin-releasing hormone), 
POMC (proopiomelanocortin), α-MSH (α-melanocortin), 
CART (cocaine- and amphetamine-regulated transcript), 
and BDNF (brain-derived neurotrophic factor) [21,48,49]. 
TNFα could also contribute to the hormonal changes and 
to the loss of appetite due to interaction with leptin and 
NPY signaling [48]. Leptin with its receptor (LepRb) and 
Table 5. Spearman rank correlation coefficients for clinical features and plasma hormone concentrations in the AN patients and the control group
Group AN Control
Age TTI B.w. TRBW %IBW BMI Age  B.w.  BMI 
LEP -0.08 -0.18 +0.18 -0.27* +0.12 +0.30* +0.17 +0.01 +0.17
C  +0.12 +0.10 +0.08 -0.13 +0.24 +0.16 -0.04 +0.04 -0.02
IRI  0.00 +0.08 -0.01 -0.13 +0.01 -0.02 +0.05 0.00 +0.09
IGF-1  -0.20 -0.13 +0.47*** -0.42*** +0.48*** +0.57*** -0.37** -0.26 -0.26
GH  -0.03 -0.11 -0.06 +0.26* -0.29* -0.10 -0.02 -0.01 +0.07
TSH  +0.14 +0.05 +0.15 -0.05 +0.04 +0.16 -0.01 -0.21 -0.14
fT3  +0.2 +0.12 +0.16 -0.06 +0.25 +0.10 -0.31* -0.32* -0.29*
fT4  +0.11 +0.27* +0.17 0.00 +0.15 -0.05 +0.14 +0.07 -0.05
LH  +0.17 +0.18 +0.21 -0.20 +0.30* +0.27* +0.09 -0.09 -0.04
FSH  +0.06 +0.29* +0.05 -0.26* +0.24* +0.23 -0.07 -0.20 -0.27
E2  +0.15 +0.33** +0.22 -0.12 +0.35** +0.21 +0.31* +0.19 +0.14
T  -0.01 -0.05 +0.40** -0.20 +0.22 +0.33* +0.17 +0.10 +0.13
*p<0.05, **p<0.01, ***p<0.001
TTI – total time of illness, B.w. – body weight, TRBW – total reduction of body weight, %IBW – percentage of ideal body weight, BMI – body mass index, LEP 
– leptin, C – cortisol, IRI – insulin, IGF-1 – insulin-like growth factor 1, GH – growth hormone, TSH – thyroid-stimulating hormone, fT3 – triiodothyronine, fT4 – 
thyroxine, LH – luteotropic hormone, FSH – follicle-stimulating hormone, E2 – estradiol, T – testosterone
Fig. 1.  Correlations of IGF-1 plasma concentration and BMI in the AN patients 
and controls. Linear regression lines and Spearman’s rank correlation 
coefficients (Rs) are presented for each group168
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the melanocortin system with MC4R signaling in neural 
and physiological pathways may be crucial for processes 
of nutritional regulation [45].
The cortisol level in the examined anorectic women 
were higher than in the controls. Our study confirmed 
the opinion that cortisol is usually elevated in anorexia 
[20,23,26,32,34,41]. According to some authors, hyper-
cortisolemia is one of the most characteristic hormon-
al symptoms in AN [32,41]. Serum cortisol at low body 
weight is a significant predictor of visceral adipose tis-
sue redistribution after weight gain [32]. On the basis 
of endocrinological observations, alteration of the CRH 
-ACTH-cortisol axis in AN is secondary to starvation [51]. 
Hypersecretion of CRH is a compensatory mechanism 
counteracting cortisol resistance in feedback regulation 
[23] which probably is involved in the vicious circle main-
taining the emaciated state [51], while a reduced rate of 
Table 6. Spearman rank correlation coefficients for plasma hormone concentrations in the AN patients
LEP C IRI IGF-1 GH TSH fT3 fT4 LH FSH E2
C -0.09
IRI +0.27* -0.03
IGF-1 +0.43*** +0.25 +0.18
GH -0.11 -0.14 -0.42*** -0.11
TSH -0.06 +0.15 -0.06 +0.17 -0.07
fT3 -0.06 +0.14 +0.07 +0.17 -0.31* +0.18
fT4 -0.25* +0.06 +0.17 +0.08 -0.27* -0.02 +0.33**
LH +0.32* +0.07 +0.16 +0.35** -0.12 +0.18 +0.27* +0.13
FSH +0.28* -0.13 -0.07 +0.26* +0.02 +0.03 +0.08 +0.07 +0.65***
E2 +0.36** -0.11 +0.08 +0.08 -0.10 +0.10 +0.16 +0.16 +0.47*** +0.42***
T +0.17 -0.06 +0.11 +0.42** -0.05 +0.12 +0.13 +0.17 +0.22 +0.16 -0.01
*p<0.05, **p<0.01, ***p<0.001 
LEP – leptin, C – cortisol, IRI – insulin, IGF-1 – insulin-like growth factor 1, GH – growth hormone, TSH – thyroid-stimulating hormone, fT3 – triiodothyronine, fT4 – 
thyroxine, LH – luteotropic hormone, FSH – follicle-stimulating hormone, E2 – estradiol, T – testosterone
Table 7. Multiple linear regression analysis (GLM) of associations between body weight parameters and patients’ age, type of anorexia (restrictive or binge-purging), 
total time of illness, and IGF-1 plasma concentration
Dependent variable Independent variables Partial correlation coefficient p
BMI
Age +0.045 0.72
Bulimic AN type +0.254 0.037
TTI +0.018 0.88
IGF-1 +0.588 <0.00001
%IBW
Age +0.038 0.76
Bulimic AN type +0.143 0.24
TTI +0.173 0.16
IGF-1 +0.516 <0.00001
TRBW
Age +0.114 0.35
Bulimic AN type +0.074 0.55
TTI -0.110 0.37
IGF-1 -0.360 0.0025
p – statistical significance of association with the dependent variable for each independent variable in the multivariate model; BMI – body mass index, %IBW – 
percentage of ideal body weight, TRBW – total reduction of body weight, TTI – total time of illness, IGF-1 – insulin-like growth factor 1169
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cortisol breakdown might be responsible for energy con-
servation [10]. We did not confirm a previously reported 
inverse correlation between cortisol and BMI in AN pa-
tients [34,41]. We observed lower cortisol secretion in 
anorectic patients with psychiatric disease in the family. 
According to a pathophysiological model, severe stress-
ors or increased plasma cortisol might trigger a host of 
harmful (brain or peripheral tissue) derangements [22]. 
This especially concerns individuals carrying a genetic 
risk for psychiatric disorders such as anorexia nervosa, 
alcoholism, and affective disorders [22,25]. In anorexia 
nervosa, neuropsychological deficits are usually linked 
to elevations in cortisol level, while the structural abnor-
malities in the brain are similar to those seen in schizo-
phrenic patients [28] who are impaired in their biological 
response to stress by showing a blunted cortisol secretion 
to psychosocial stress [17]. Up to 90% of AN patients dem-
onstrate depressive symptoms during the acute phase of 
illness [28]. 
The level of insulin was lower in the AN than in the con-
trol women. Such results are typical of chronic starvation 
[2]. No correlations between IRI and the clinical param-
eters were found except for the association of IRI and 
domestic violence. Some authors assume that women 
who have experienced parental physical and psychologi-
cal abuse demonstrate more anorexic behavior [33,43]. 
However, complete suppression of appetite is doubtful 
because of the underlying volitional and, usually, ego-
syntonic resistance to eating drives [25]. On the other 
hand, proper parenthood with encouragement of child 
autonomy is associated with less dieting behavior, possi-
bly serving a protective function against eating disorders 
[43]. Family violence is an extremely powerful trigger 
which may lead to activation of the glucose-insulin-cor-
tisol-related pathways in autonomic response to psycho-
logical distress and requires further exploration. 
IGF-1 was significantly lower and GH significantly high-
er in the AN group than in the controls and compa-
rable in the AN-R and AN-B subgroups [11,50]. Adap-
tation to chronic starvation induces exaggerated GH 
and decreased IGF-1 secretion. Such changes are ex-
plained by disturbed control of hypothalamic GH re-
lease [46,47,50,51], peripheral GH resistance [47,51], and 
decreased levels of growth hormone-binding protein 
(GHBP) [30], leading to reduced IGF-1 synthesis [16] and 
impairment of the negative IGF-1 feedback action on 
GH release [16,52]. However, the peripheral IGF-1 sys-
tem may be independent of any modifications in GH 
concentration [3], so that some anorectic patients may 
have diminished GH despite decreased IGF-1 secretion 
[18]. Our results support the notion that IGF-1 and GH 
are sensitive to chronic malnutrition [7] as these hor-
mones significantly correlated with TRBW and %IBW. 
Following Stǿving et al., we demonstrated that IGF-1 
plasma level showed the strongest correlations with 
each of the analyzed body weight parameters irrespec-
tive of the clinical subtype of illness [50]. These data 
are congruent with hypotheses that hormonal changes 
are secondary to nutritional deprivation [7,18,47] and 
that nutritional status may be a major determinant in 
the regulation of the somatotropin-somatomedin axis 
in humans [2,47]. Bioactivity of IGF-1 may be a suitable 
marker in emaciated patients with AN [50] as well as 
in other conditions of malnutrition and malabsorption 
[16]. On the other hand, these mechanisms connected 
with increased GH and decreased IGF-1 secretion ap-
pear to be protective of the self-destructive stress re-
action called self-cannibalism [51], typically observed 
in long-lasting critical illness [46]. In this context, the 
positive correlation between IGF-1 and BMI in AN with a 
tendency to a negative correlation in the control group 
confirms a close relationship between IGF-1 secretion 
and nutrition state. In Figure 1 it can be observed that a 
BMI of 18.5 kg/m2, which was arbitrarily determined as 
the boundary for anorexia nervosa diagnosis, is where 
the IGF-1 levels in the AN and control groups intersect. 
Thus plasma IGF-1 may be suggested as a sensitive hor-
monal marker of cachexia. It should be verified whether 
the level of 300 μg/L IGF-1, which corresponds to a BMI 
of 18.5 kg/m2, might be of diagnostic value (Figure 1). 
Our results may support the hypothesis of Gianotti et 
al. [16] that the activity of the GH/IGF-1 axis in AN re-
flects only an impaired nutritional state and cannot be 
considered a primary hallmark of the disease.
Anorexia nervosa is usually associated with markedly 
decreased total and free T3, normal or subnormal total 
and free T4, and normal or lower TSH concentrations 
described as “low T3 syndrome” or “sick euthyroid syn-
drome” [27,44]. Our results are in agreement with this 
profile. The thyroid axis adapts its activity to weight sta-
tus [44] and leptin is believed to be the link between body 
weight and TSH [38]. However, no correlation between 
TSH and body weight parameters was found previously 
[5] or in our AN patients. Such results may explain the 
adaptive mechanisms in AN responsible for cell energy 
expenditure.
Hypogonadotropic hypogonadism, a major diagnostic 
criterion of AN [41], is a final clinical effect of adaptive 
responses to pathological dieting and extreme under-
nutrition [9]. Our results confirm that serum gonado-
tropins and estradiol in AN (independent of subtype) 
are significantly decreased compared with the control 
group [32,50,53]. Our data showing that LH positively 
correlated with BMI [41,53], and FSH with duration of 
illness [53], are also in agreement with other reports. 
These changes are parallel to disturbances in the GH-
IGF-1 and corticotrophin axes described above [4,34] and 
decreased serum levels of leptin, IGF-1, and T3, which 
are supposed to be nutritional markers of FHA (func-
tional hypothalamus amenorrhea) [8,39]. Two metabolic 
determinants are important for primary or secondary 
amenorrhea. Low fat content in a range of 10-15% body 
weight is associated with cessation of menstrual cycles 
[14]. The second clinical determinant is leptin level – its 
serum concentration of 1.85 ng/mL is required to main-
tain menstruation [29]. 170
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In our study we observed positive associations of tes-
tosterone with alcohol and drug abuse in AN patients. 
Regarding the biological spectrum of testosterone, such 
observations could explain the proneness to impulsivity 
in anorexia. As individuals with the binge eating/purg-
ing subtype of AN are more often classified as likely to 
have histories of behavioral dyscontrol, substance abuse, 
and overt family conflict [25], the similar plasma levels 
of testosterone in both analyzed subgroups might show 
the better mechanisms of emotional control in AN-R than 
in AN-B patients. 
A limitation of our study is significantly older age of fe-
males in the control group (Table 3). It was connected 
with ethical constraints in obtaining informed consent 
for examination of healthy adolescents. However, it is 
unlikely that the observed differences in hormone con-
centrations between groups were strongly influenced 
by an age difference equal to 5 years, and the main aim 
of our study was to explore the relationships within the 
anorexia group. Further research is needed to explain the 
role of many other neurotransmitters and inflammatory 
agents in AN and their interactions with genetic and en-
vironmental factors. 
conclusIons
Our study confirmed that there is feedback regulation be-
tween nutritional state, leptin, and the concentrations of 
a broad spectrum of hormones involved in the stress reac-
tion which affect glucose, lipid, and protein metabolism, 
regulate energy expenditure, and influence reproductive 
function in women with anorexia nervosa. The somato-
tropin-somatomedin, gonadal, and corticotrophin axes 
activity may be helpful in assessing the clinical stage in 
anorexia nervosa. Plasma IGF-1 seems to be the most sen-
sitive and useful independent hormonal marker of cache-
xia. The associations of stressful life events, personality 
predisposition, hormone secretion, eating behavior, and 
nutritional state are evident and require further explo-
ration to better understand the phenomenon of anorexia 
nervosa and to help monitor the disease.
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